Tonic BCR signaling presents in the GCB DLBCL subtype, which is mechanistically distinct from chronic active BCR signaling since it does not engage BTK, CARD11, or NF-κB [159]. This evidence concerns the gene BCR and diffuse large B-cell lymphoma.